The objectives of this analysis were to describe (i) the demographics and clinical characteristics, (ii) patterns of care, (iii) real‐world outcomes, and (iv) safety outcomes of patients with NSCLC and EGFR ex20ins mutations. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.